Visium to invest up to $60.5 million in Boulder-based SomaLogic

BOULDER — SomaLogic Inc., on Tuesday announced that the company has raised up to $60.5 million in equity and debt financing from Visium Healthcare Partners to help the growing Boulder-based firm accelerate the rollout of its diagnostic tests to hospitals and medical clinics.

Specifics of the funding related to milestones and the size of the equity stake were not disclosed.

SomaLogic makes a SOMAscan assay that can be used to analyze a variety of biological samples and quickly and accurately read out thousands of proteins present for the purposes of diagnosing and understanding the biology of diseases.

Founded in 2000, SomaLogic began marketing…